Renal agents

Coroner raises concerns over lack of national guidance on prescribing for hepatitis B reactivation

A patient died from complications from reactivation of hepatitis B, after the supply of viral reactivation prophylaxis was inadvertently discontinued.…

‘Game-changing’ urine test could identify correct antibiotic for UTI within hours

The researchers found that the urine test could provide results in an average of 5.85 hours, while the current laboratory testing methods could take two to three days.…

Health news round-up: Alzheimer’s treatment, retatrutide results and kidney cancer guidelines

A weekly summary of important developments in pharmacy and health news that you may have missed.…

Urinary tract infection in children: diagnosis and management

An overview of the diagnosis and empirical management of urinary tract infections in children.…

More than 20% of adults think UTIs can be prevented with precautionary antibiotics

A survey commissioned by the European Association of Urology also revealed that nearly 20% of UK adults believed that antibiotics are always needed for urinary tract infections.…

Health news round up: long-term conditions, cancer drugs and a medicines pricing stand-off

Senior clinical reporter Joanna Robertson summarises some important developments in health news.…

MHRA approves first new UTI antibiotic in 30 years

Gepotidacin (Blujepa; GSK) is approved for the treatment of uncomplicated UTIs in patients aged 12 years and over, who weigh at least 40kg.…

Haemodialysis and peritoneal dialysis: an overview

A summary of the different types of renal replacement therapy and the physiological implications of end-stage renal disease on medicines dosing and monitoring.…

Optimising use of SGLT2 inhibitors in hospital patients

How pharmacists can evaluate SGLT2 inhibitor use in hospitalised patients with a well-balanced approach so that patients can simultaneously benefit from SGLT2 inhibitors and the reduction of diabetic ketoacidosis risk.…

NICE recommends vadadustat for anaemia during dialysis for chronic kidney disease

Draft guidance says that vadadustat is a cost-effective oral alternative to erythropoiesis stimulating agents for the treatment of anaemia in patients with chronic kidney disease receiving dialysis.…